Open access discounts
If you are publishing Gold Open Access, you may be eligible for an APC waiver or discount. Please see this journal's open access options for details.
Once an article has been accepted, the process of copyediting, proofing, typesetting and publishing the article will begin. Authors will be asked to ensure all final files are submitted to ScholarOne before the article can be sent to Cambridge University Press for production.
Your point of contact with Cambridge University Press will be the content manager of the journal. For more information about how production works at Cambridge University Press, please see our information on publishing an accepted paper, which explains how an article goes from accepted manuscript to fully published. There may be small differences between journals with this process. You can also check our Journal Production FAQs.
For manuscripts describing COVID-19 and coronavirus-related publications, we are taking steps to help authors make their work available to read and cite more quickly. This includes expediting the publication process for COVID-19 papers.
- Authors should share important information with public health authorities. We encourage all authors to share all data about the 2019-nCoV outbreak in confidence with the World Health Organization. The WHO is asking that submissions/pre-prints be sent to email@example.com.
- Authors are encouraged to post submitted relevant manuscripts under review to bioRxiv, medRxiv or other relevant pre-print server. Cambridge's Preprint Policy explicitly allows authors to share manuscripts in this way prior to publication in a Cambridge journal.
The Press plays a global role in education and research and shares the University’s mission to contribute to society through our work. Sharing research can play an important role in tackling shared threats. As such, we have created a special collection of free-to-read articles and book chapters related to the coronavirus that will be continually updated as new research becomes available.